Functional state of the myocardium and criteria for poor prognosis in mitral valve prolapse

Abstract

Aim. Study of the fnctional state of left ventricular myocardium and determination of diagnostic criteria of poor prognosis of mitral valve prolapse.

Methods. 151 patients (116 males and 35 females) with mitral valve prolapse (MVP) were examined. The average age was 34.8 ± 0.79 years. Division by the groups was performed depending on the severity of structural changes of the valve and width of the cusps: group 1 included 54 patients with classic form of MVP (cusp width ≥5 mm), group 2 included 55 patients with cusp width ≥3 mm, group 3 included 42 patients with MV cusp width less than 3 mm. All patients underwent complex clinical functional examination of cardiovascular system. The state of systolic and diastolic cardiac function was assessed using stationary high-tech ultrasound scanner «Philips iE-33» (Philips, Holland) according to conventional technique with determination of standard heart parameters and calculation of intracardiac hemodynamic parameters. Echocardiography was performed on admission and 12 to 18 month later.

Results. The study revealed that the most prominent changes of cardiohemodynamics and unfavorable disease course were observed in 72.2 % of patients with classic form of MVP (group 1). Patients with non-classic form of MVP (group 2) also had poor prognosis in 27.8 % of cases. Diagnostic criteria of poor prognosis of MVP according to echocardiography were determined: severe mitral regurgitation (degree ≥III), mitral valve cusp thickness during diastole over 6 mm, left ventricle dilation (EDS ≥ 60 mm; ESS ≥ 36 mm), left atrial dilation (anterior posterior size of LA ≥ 40 mm, LA volume ≥ 80 ml), mitral annulus dilation (diameter of MA ≥ 35 mm).

Conclusion. Differences of functional state of the myocardium of left ventricle were revealed depending on the type of mitral valve prolapse caused by the severity of connective tissue dysplasia. In classic form of MVP more severe disorders of intracardiac hemodynamics were observed as well as more severe mitral insufficiency.

Keywords

mitral valve prolapse / poor prognosis

References

[1] Abdrakhmanova A.I., Abdulyanov I.V. Mitral valve prolapse in medical practice. Prakticheskaya meditsina. 2015; (3-2): 17–24. (In Russ.)

[2] Абдрахманова А.И., Абдульянов И.В. Пролапс митрального клапана в практике врача. Практическая медицина. 2015; (3-2): 17-24.

[3] Vahanian A., Alfieri O., Andreotti F., et al. Guidelines on the management of valvular heart disease (version 2012). Eur. Heart J. 2012; 19: 2451–2496. DOI: 10.1093/

[4] Vahanian A., Alfieri O., Andreotti F., et al. Guidelines on the management of valvular heart disease (version 2012). Eur. Heart J. 2012; 19: 2451-2496. DOI: 10.1093/ eurheartj/ehs109.

[5] eurheartj/ehs109.

[6] Назаров В.М., Афанасьев А.В., Демин И.И. Коррекция митральной недостаточности при болезни Барлоу. Патология кровообращения и кардиохирургия. 2014; (1): 70-73. DOI: 10.21688/1681-3472-2014-1-70-73.

[7] Nazarov V.M., Afanas’ev A.V., Demin I.I. Correction of mitral insufficiency in Barlow disease. Circulation pathology and cardiac surgery. 2014; (1): 70–73. (In Russ.)

[8] Бова А.А., Рудой А.С., Лысый Ю.С. Пролапс митрального клапана: ошибки диагностики, экспертные подходы. Медицинские новости. 2011; (11): 17-21.

[9] Bova A.A., Rudoy A.S., Lysyy Yu.S. Mitral valve prolapse: errors of diagnosis, expert approaches. Meditsinskie novosti. 2011; (11): 17–21. (In Russ.)

[10] Малев Э.Г., Земцовский Э.В., Желнинова Т.А. и др. Распространенность пролапса митрального клапана в российской популяции. Трансляционная медицина. 2011; (5): 113-118.

[11] Malev E.G., Zemtsovskiy E.V., Zhelninova T.A. et al. The incidence of mitral valve prolapse in the Russian population. Translyatsionnaya ­meditsina. 2011; (5): 113–118. (In Russ.)

[12] Кужель Д.А., Матюшин Г.В., Савченко Е.А. Диагностика и лечение пролапса митрального клапана. Рациональная фармакотерапия в кардиологии. 2010; 6 (4): 539-542.

[13] Кужель Д.А., Матюшин Г.В., Савченко Е.А. Диа­г-

[14] Наследственные нарушения соединительной ткани в кардиологии. Диагностика и лечение. Российские рекомендации (I пересмотр). Российский кардиологический журнал. 2013; (1 s1): 2-32. DOI: 10.15829/1560-4071-2013-1s1-5-32.

[15] Kuzhel’ D.A., Matyushin G.V., Savchenko E.A. Diagnosis and treatment of mitral valve prolapse. Ratsional'naya farmakoterapiya v kardiologii. 2010; 6 (4): 539–542. (In Russ.)

[16] Hereditary connective tissue disorders in cardiology. Diagnosis and treatment. Russian guidelines (revision). Rossiyskiy kardiologicheskiy zhurnal. 2013; (1 s1): 2–32. (In Russ.)

RIGHTS & PERMISSIONS

Gadzhieva L.R., Muracheva N.V., Tkachenko S.B.